Therapeutic Advances in Endocrinology and Metabolism

Papers
(The TQCC of Therapeutic Advances in Endocrinology and Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic80
COVID-19 and the hidden threat of diabetic microvascular complications41
Evaluating the precision and reliability of real-time continuous glucose monitoring systems in ambulatory settings: a systematic review40
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review27
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults20
Response to a low-energy meal replacement plan on glycometabolic profile and reverse cardiac remodelling in type 2 diabetes: a comparison between South Asians and White Europeans19
Patient-perceived benefits and risks of off-label use of SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes: a structured qualitative assessment19
Gut microbiota in MAFLD: therapeutic and diagnostic implications16
Real-world evidence of the use of glucocorticoids for severe COVID-1916
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study15
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice15
Role of inflammation in diabetic cardiomyopathy14
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review14
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions14
Diagnostic efficacy of aldosterone-to-renin ratio to screen primary aldosteronism in hypertension: a systemic review and meta-analysis14
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis13
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity13
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study12
Timing of osteoporosis therapies following fracture: the current status12
Controversies in the management of active Charcot neuroarthropathy11
A case of pheochromocytoma associated with liver abscess and intestinal pseudo-obstruction11
Amputation versus circular external fixation in the treatment of diabetic foot with osteomyelitis: a cost and quality-of-life analysis10
Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication10
Serum vitamin B12 levels and glycemic fluctuation in patients with type 2 diabetes mellitus9
A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke9
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease9
HbA1c changes in the first year post-kidney transplant and associated risk factors in a Saudi cohort9
Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis8
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review8
Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications8
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease8
Exploring the mechanism of metformin action in Alzheimer’s disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation8
0.18488502502441